Compare VSH & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSH | INDV |
|---|---|---|
| Founded | 1962 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.4B |
| IPO Year | 1994 | 2014 |
| Metric | VSH | INDV |
|---|---|---|
| Price | $37.96 | $40.48 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 1.6M |
| Earning Date | 05-13-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | 69.57 | ★ 8100.00 |
| EPS | 0.05 | ★ 0.69 |
| Revenue | ★ $3,069,048,000.00 | $1,239,000,000.00 |
| Revenue This Year | $12.58 | N/A |
| Revenue Next Year | $6.69 | N/A |
| P/E Ratio | $816.00 | ★ $58.71 |
| Revenue Growth | ★ 4.48 | 4.29 |
| 52 Week Low | $11.77 | $16.69 |
| 52 Week High | $69.47 | $42.81 |
| Indicator | VSH | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 53.87 |
| Support Level | $15.33 | $39.20 |
| Resistance Level | $68.06 | $41.42 |
| Average True Range (ATR) | 2.94 | 1.37 |
| MACD | -0.43 | -0.15 |
| Stochastic Oscillator | 33.82 | 56.03 |
Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).